Advanced search
Publication Cover
Drug Delivery Volume 23, 2016 - Issue 4: Liposome- and lipid-based drug delivery
Submit an article Journal homepage
2,685
Views
54
CrossRef citations to date
0
Altmetric
Research Article

Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity

Jie TangKey Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, China and ;Department of Pharmaceutical Engineering, School of Bioengineering, Xihua University, Chengdu, China
,
Li ZhangKey Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, China and
,
Huile GaoKey Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, China and
,
Yayuan LiuKey Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, China and
,
Qianyu ZhangKey Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, China and
,
Rui RanKey Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, China and
,
Zhirong ZhangKey Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, China and
&
Qin HeKey Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, China and Correspondence[email protected]
 show all
Pages 1130-1143 | Received 03 Oct 2014, Accepted 18 Nov 2014, Published online: 10 Dec 2014

Citations (54)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Ashwaq A. Al-Mutairi & Mayson H. Alkhatib. (2022) Antitumour effects of a solid lipid nanoparticle loaded with gemcitabine and oxaliplatin on the viability, apoptosis, autophagy, and Hsp90 of ovarian cancer cells. Journal of Microencapsulation 39:5, pages 467-480.
Read now
Megha Rachmale, Niraj Rajput, Tarang Jadav, Amit Kumar Sahu, Rakesh K. Tekade & Pinaki Sengupta. (2022) Implication of metabolomics and transporter modulation based strategies to minimize multidrug resistance and enhance site-specific bioavailability: a needful consideration toward modern anticancer drug discovery. Drug Metabolism Reviews 54:2, pages 101-119.
Read now
Hend E. Abo Mansour, Maha M. El-Batsh, Nadia S. Badawy, Eman T. Mehanna, Noha M. Mesbah & Dina M. Abo-Elmatty. (2021) Ginger Extract Loaded into Chitosan Nanoparticles Enhances Cytotoxicity and Reduces Cardiotoxicity of Doxorubicin in Hepatocellular Carcinoma in Mice. Nutrition and Cancer 73:11-12, pages 2347-2362.
Read now
Yurui Xu, Sajid Asghar, Shiya Gao, Zhipeng Chen, Lin Huang, Lining Yin, Qineng Ping & Yanyu Xiao. (2017) Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor. International Journal of Nanomedicine 12, pages 7337-7350.
Read now
Tianqi Wang, Lixia Feng, Shaomei Yang, Yongjun Liu & Na Zhang. (2017) Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency. Drug Delivery 24:1, pages 800-810.
Read now
Qiuxia Ding, Zhi Li, Yi Yang, Gang Guo, Feng Luo, Zhengqiong Chen, Ying Yang, ZhiYong Qian & Shuai Shi. (2016) Preparation and therapeutic application of docetaxel-loaded poly(d,l-lactide) nanofibers in preventing breast cancer recurrence. Drug Delivery 23:8, pages 2677-2685.
Read now

Articles from other publishers (48)

Krešimir Pavelić, Sandra Kraljević Kraljević Pavelić, Aleksandar Bulog, Andrea Agaj, Barbara Rojnić, Miroslav Čolić & Dragan Trivanović. (2023) Nanoparticles in Medicine: Current Status in Cancer Treatment. International Journal of Molecular Sciences 24:16, pages 12827.
Crossref
Shi-Jie Hao, Ya-Xuan Zhu & Fu-Gen Wu. (2023) Membrane fusion-mediated delivery of small-molecule HER2 tyrosine kinase inhibitor for effective tumor chemosensitization. Journal of Controlled Release 357, pages 222-234.
Crossref
Chang Hyun Kim, Sangkil Lee, Ji Yeh Choi, Min Jeong Lyu, Hyun Min Jung, Yoon Tae Goo, Myung Joo Kang & Young Wook Choi. (2023) Functionalized Lipid Nanocarriers for Simultaneous Delivery of Docetaxel and Tariquidar to Chemoresistant Cancer Cells. Pharmaceuticals 16:3, pages 349.
Crossref
Fan Yang, Qingjie He, Xiangpeng Dai, Xiaoling Zhang & Dong Song. (2023) The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies. Frontiers in Pharmacology 14.
Crossref
Puja Ghosh, Himja Tiwari, Jaya Lakkakula, Arpita Roy, Talha Bin Emran, Summya Rashid, Saad Alghamdi, Bodour S. Rajab, Mazen Almehmadi, Mamdouh Allahyani, Abdulelah Aljuaid, Ahad Amer Alsaiari, Rohit Sharma & Ahmad O. Babalghith. (2022) A decade's worth of impact: Dox loaded liposomes in anticancer activity. Materials Today Advances 16, pages 100313.
Crossref
Priya Yadav, Suresh V. Ambudkar & N. Rajendra Prasad. (2022) Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer. Journal of Nanobiotechnology 20:1.
Crossref
Yao Wendong, Xu Hengwu, Chen Yanhong, Xu Yingying, Zhou Feng, Wang Zeng & Cai Xinjun. (2022) Mannose modified co-loaded zoledronic liposomes deplete M2-tumor-associated macrophages to enhance anti-tumor effect of doxorubicin on TNBC. Journal of Drug Delivery Science and Technology 74, pages 103551.
Crossref
Chang Hyun Kim, Tae Hwa Lee, Byoung Deok Kim, Hyeon Kyun Kim, Min Jeong Lyu, Hyun Min Jung, Yoon Tae Goo, Myung Joo Kang, Sangkil Lee & Young Wook Choi. (2022) Co-administration of tariquidar using functionalized nanostructured lipid carriers overcomes resistance to docetaxel in multidrug resistant MCF7/ADR cells. Journal of Drug Delivery Science and Technology 71, pages 103323.
Crossref
Yan Shan Loo, N. Idayu Zahid, Thiagarajan Madheswaran & Intan Diana Mat Azmi. (2022) Recent advances in the development of multifunctional lipid-based nanoparticles for co-delivery, combination treatment strategies, and theranostics in breast and lung cancer. Journal of Drug Delivery Science and Technology 71, pages 103300.
Crossref
Manita Das, Apeksha Joshi, Ranjitsinh Devkar, Sriram Seshadri & Sonal Thakore. (2022) Vitamin-H Channeled Self-Therapeutic P-gp Inhibitor Curcumin-Derived Nanomicelles for Targeting the Tumor Milieu by pH- and Enzyme-Triggered Hierarchical Disassembly. Bioconjugate Chemistry 33:2, pages 369-385.
Crossref
Sepideh Mirzaei, Mohammad Hossein Gholami, Farid Hashemi, Amirhossein Zabolian, Mahdi Vasheghani Farahani, Kiavash Hushmandi, Ali Zarrabi, Aaron Goldman, Milad Ashrafizadeh & Gorka Orive. (2022) Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects. Drug Discovery Today 27:2, pages 436-455.
Crossref
Ishwor Poudel, Manjusha Annaji, Robert D. Arnold, Virendra Gajbhiye, Amit K. Tiwari & R. Jayachandra Babu. 2022. Stimuli-Responsive Nanocarriers. Stimuli-Responsive Nanocarriers 61 86 .
Minsu Kim, Seok Chan Park & Dong Yun Lee. (2021) Glycyrrhizin as a Nitric Oxide Regulator in Cancer Chemotherapy. Cancers 13:22, pages 5762.
Crossref
Antonia I. Antoniou, Sabrina Giofrè, Pierfausto Seneci, Daniele Passarella & Sara Pellegrino. (2021) Stimulus-responsive liposomes for biomedical applications. Drug Discovery Today 26:8, pages 1794-1824.
Crossref
Aditi D. Fulfager & Khushwant S. Yadav. (2021) Understanding the implications of co-delivering therapeutic agents in a nanocarrier to combat multidrug resistance (MDR) in breast cancer. Journal of Drug Delivery Science and Technology 62, pages 102405.
Crossref
Vivek Makwana, Jasmine Karanjia, Thomas Haselhorst, Shailendra Anoopkumar-Dukie & Santosh Rudrawar. (2021) Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization. International Journal of Pharmaceutics 593, pages 120117.
Crossref
Jerónimo Laiolo, Cecilia L. Barbieri, Mariana B. Joray, Priscila A. Lanza, Sara M. Palacios, D. Mariano A. Vera & María C. Carpinella. (2021) Plant extracts and betulin from Ligaria cuneifolia inhibit P-glycoprotein function in leukemia cells. Food and Chemical Toxicology 147, pages 111922.
Crossref
Paras Famta, Saurabh Shah, Essha Chatterjee, Hoshiyar Singh, Biswajit Dey, Santosh Kumar Guru, Shashi Bala Singh & Saurabh Srivastava. (2021) Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms. Current Research in Pharmacology and Drug Discovery 2, pages 100054.
Crossref
Ahmed Al Saqr, Mohammed F. Aldawsari, Hamad Alrbyawi, Ishwor Poudel, Manjusha Annaji, Vanisree Mulabagal, Modukuri V. Ramani, Subbaraju Gottumukkala, Amit K. Tiwari, Muralikrishnan Dhanasekaran, Peter R. Panizzi, Robert D. Arnold & R. Jayachandra Babu. (2020) Co-Delivery of Hispolon and Doxorubicin Liposomes Improves Efficacy Against Melanoma Cells. AAPS PharmSciTech 21:8.
Crossref
HE Abo Mansour, MM El-Batsh, NS Badawy, ET Mehanna, NM Mesbah & DM Abo-Elmatty. (2020) Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice. Human & Experimental Toxicology 39:11, pages 1528-1544.
Crossref
Elaheh Mirhadi, Mohammad Mashreghi, Mahdi Faal Maleki, Seyedeh Hoda Alavizadeh, Leila Arabi, Ali Badiee & Mahmoud Reza Jaafari. (2020) Redox-sensitive nanoscale drug delivery systems for cancer treatment. International Journal of Pharmaceutics 589, pages 119882.
Crossref
Lijuan Zhu, Yuanyuan Guo, Qiuhui Qian, Deyue Yan, Yuehua Li, Xinyuan Zhu & Chuan Zhang. (2020) Carrier‐Free Delivery of Precise Drug–Chemogene Conjugates for Synergistic Treatment of Drug‐Resistant Cancer. Angewandte Chemie International Edition 59:41, pages 17944-17950.
Crossref
Lijuan Zhu, Yuanyuan Guo, Qiuhui Qian, Deyue Yan, Yuehua Li, Xinyuan Zhu & Chuan Zhang. (2020) Carrier‐Free Delivery of Precise Drug–Chemogene Conjugates for Synergistic Treatment of Drug‐Resistant Cancer. Angewandte Chemie 132:41, pages 18100-18106.
Crossref
Alessandro Dalpiaz, Guglielmo Paganetto, Giada Botti & Barbara Pavan. (2020) Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance?. Drug Discovery Today 25:9, pages 1651-1667.
Crossref
Jin Gao, Xinyue Dong & Zhenjia Wang. (2020) Generation, purification and engineering of extracellular vesicles and their biomedical applications. Methods 177, pages 114-125.
Crossref
Qiuyi Li & Yuan Huang. (2020) Mitochondrial targeted strategies and their application for cancer and other diseases treatment. Journal of Pharmaceutical Investigation 50:3, pages 271-293.
Crossref
Maryam Majidinia, Mohammad Mirza‐Aghazadeh‐Attari, Mahdi Rahimi, Ainaz Mihanfar, Ansar Karimian, Amin Safa & Bahman Yousefi. (2020) Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons. IUBMB Life 72:5, pages 855-871.
Crossref
Francesca Rolle, Valeria Bincoletto, Elena Gazzano, Barbara Rolando, Giovanna Lollo, Barbara Stella, Chiara Riganti & Silvia Arpicco. (2020) Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells. International Journal of Pharmaceutics 580, pages 119191.
Crossref
Xu Cheng, Xiaodong Lv, Jiaxi Xu, Yan Zheng, Xin Wang & Rupei Tang. (2020) Pluronic micelles with suppressing doxorubicin efflux and detoxification for efficiently reversing breast cancer resistance. European Journal of Pharmaceutical Sciences 146, pages 105275.
Crossref
Kambere Amerigos Daddy J.C.Minglei Chen, Faisal Raza, Yanyu Xiao, Zhigui Su & Qineng Ping. (2020) Co-Encapsulation of Mitoxantrone and β-Elemene in Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Leukemia. Pharmaceutics 12:2, pages 191.
Crossref
Oliver S. Thomas & Wilfried Weber. (2019) Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?. Frontiers in Bioengineering and Biotechnology 7.
Crossref
Hongwei Liao, Zeyu Liang, Nan Wang, Min Wei, Ying Chen, Fangyuan Li & Daishun Ling. (2019) Dynamic supraparticles for the treatment of age-related diseases. Science Bulletin 64:24, pages 1850-1874.
Crossref
Okhil K. Nag & James B. Delehanty. (2019) Active Cellular and Subcellular Targeting of Nanoparticles for Drug Delivery. Pharmaceutics 11:10, pages 543.
Crossref
Mahnaz Saraei, Raana Sarvari, Bakhshali Massoumi & Samira Agbolaghi. (2019) Co‐delivery of methotrexate and doxorubicin via nanocarriers of star‐like poly(DMAEMA‐ block ‐HEMA‐ block ‐AAc) terpolymers . Polymer International 68:10, pages 1795-1803.
Crossref
Xin Wang, Xu Cheng, Le He, Xiaoli Zeng, Yan Zheng & Rupei Tang. (2019) Self-Assembled Indomethacin Dimer Nanoparticles Loaded with Doxorubicin for Combination Therapy in Resistant Breast Cancer. ACS Applied Materials & Interfaces 11:32, pages 28597-28609.
Crossref
Minglu Zhou, Lijia Li, Lian Li, Xi Lin, Fengling Wang, Qiuyi Li & Yuan Huang. (2019) Overcoming chemotherapy resistance via simultaneous drug-efflux circumvention and mitochondrial targeting. Acta Pharmaceutica Sinica B 9:3, pages 615-625.
Crossref
Li Kong, Frederick Campbell & Alexander Kros. (2019) DePEGylation strategies to increase cancer nanomedicine efficacy. Nanoscale Horizons 4:2, pages 378-387.
Crossref
Krassimira Yoncheva, Maria Merino, Aslihan Shenol, Nikolay T. Daskalov, Petko St. Petkov, Georgi N. Vayssilov & Maria J. Garrido. (2019) Optimization and in-vitro/in-vivo evaluation of doxorubicin-loaded chitosan-alginate nanoparticles using a melanoma mouse model. International Journal of Pharmaceutics 556, pages 1-8.
Crossref
Kaili Wang, Mengjiao Qi, Chunjing Guo, Yueming Yu, Bingjie Wang, Lei Fang, Mengna Liu, Zhen Wang, Xinxin Fan & Daquan Chen. (2018) Novel Dual Mitochondrial and CD44 Receptor Targeting Nanoparticles for Redox Stimuli-Triggered Release. Nanoscale Research Letters 13:1.
Crossref
Shian-Ren Lin & Ching-Feng Weng. (2018) PG-Priming Enhances Doxorubicin Influx to Trigger Necrotic and Autophagic Cell Death in Oral Squamous Cell Carcinoma. Journal of Clinical Medicine 7:10, pages 375.
Crossref
Ali Raza, Uzma Hayat, Tahir Rasheed, Muhammad Bilal & Hafiz M.N. Iqbal. (2018) Redox-responsive nano-carriers as tumor-targeted drug delivery systems. European Journal of Medicinal Chemistry 157, pages 705-715.
Crossref
Sen Lin, Peiling Xie, Mengmeng Luo, Qing Li, Ling Li, Jinzhao Zhang, Qinxiang Zheng, Hao Chen & Kaihui Nan. (2018) Efficiency against multidrug resistance by co-delivery of doxorubicin and curcumin with a legumain-sensitive nanocarrier. Nano Research 11:7, pages 3619-3635.
Crossref
Hongxu Lu & Martina H. Stenzel. (2018) Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles. Small 14:13, pages 1702858.
Crossref
Eugenia Pugliese, João Q. Coentro & Dimitrios I. Zeugolis. (2018) Advancements and Challenges in Multidomain Multicargo Delivery Vehicles. Advanced Materials 30:13.
Crossref
Yingying Chi, Xuelei Yin, Kaoxiang Sun, Shuaishuai Feng, Jinhu Liu, Daquan Chen, Chuanyou Guo & Zimei Wu. (2017) Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models. Journal of Controlled Release 261, pages 113-125.
Crossref
Tongxing Cui, Sihao Zhang & Hong Sun. (2017) Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment. Oncology Reports 37:2, pages 1253-1260.
Crossref
Mahdi Rahimi, Kazem D. Safa & Roya Salehi. (2017) Co-delivery of doxorubicin and methotrexate by dendritic chitosan-g-mPEG as a magnetic nanocarrier for multi-drug delivery in combination chemotherapy. Polymer Chemistry 8:47, pages 7333-7350.
Crossref
Naveen Chella & Nalini R. Shastri. 2017. Particulate Technology for Delivery of Therapeutics. Particulate Technology for Delivery of Therapeutics 253 289 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.